Dynavax Technologies Corp (NASDAQ:DVAX)

15.95
Delayed Data
As of Jun 18
 -0.20 / -1.24%
Today’s Change
7.95
Today|||52-Week Range
24.45
-14.71%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close16.15
Today’s open15.95
Day’s range15.80 - 16.11
Volume687,422
Average volume (3 months)1,615,524
Market cap$1.2B
Data as of 4:00pm ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)+38.01%
Earnings growth (this year)-35.25%
Earnings growth (next 5 years)--
Revenue growth (last year)-97.04%
P/E ratioNM
Price/Sales3,008.76
Price/Book6.15

Competitors

 Today’s
change
Today’s
% change
CLLSCellectis SA-0.91-2.99%
XNCRXencor Inc-0.46-1.14%
DERMDermira Inc+0.28+2.79%
AIMTAimmune Therapeutics...+0.28+0.92%
Data as of 4:00pm ET, 06/18/2018

Financials

Next reporting dateAugust 6, 2018
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$327.0K
Annual profit (last year)-$95.2M
Net profit margin-29,099.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts